227 related articles for article (PubMed ID: 1687290)
1. Coexistence of fusion receptors for human T-cell leukemia virus type-I (HTLV-I) and human immunodeficiency virus type-1 (HIV-1) on MOLT-4 cells.
Kannagi M; Kuroda MJ; Maeda Y; Harada S
Microbiol Immunol; 1991; 35(9):729-40. PubMed ID: 1687290
[TBL] [Abstract][Full Text] [Related]
2. Fusion activity dissociated from replication ability in feline immunodeficiency virus (FIV) in human cells.
Tochikura TS; Tanabe-Tochikura A; Hayes KA; Lazo A; Bailer RT; Blakeslee JR; Lafrado LJ; Roy-Burman P; Pandey R; Olsen RG
J Acquir Immune Defic Syndr (1988); 1993 Dec; 6(12):1301-10. PubMed ID: 8254466
[TBL] [Abstract][Full Text] [Related]
3. Identification of membrane antigen C33 recognized by monoclonal antibodies inhibitory to human T-cell leukemia virus type 1 (HTLV-1)-induced syncytium formation: altered glycosylation of C33 antigen in HTLV-1-positive T cells.
Fukudome K; Furuse M; Imai T; Nishimura M; Takagi S; Hinuma Y; Yoshie O
J Virol; 1992 Mar; 66(3):1394-401. PubMed ID: 1738199
[TBL] [Abstract][Full Text] [Related]
4. Syncytium-inhibiting monoclonal antibodies produced against human T-cell lymphotropic virus type 1-infected cells recognize class II major histocompatibility complex molecules and block by protein crowding.
Hildreth JE
J Virol; 1998 Dec; 72(12):9544-52. PubMed ID: 9811687
[TBL] [Abstract][Full Text] [Related]
5. Syncytium formation and destruction of bystander CD4+ cells cocultured with T cells persistently infected with human immunodeficiency virus as demonstrated by flow cytometry.
Schols D; Pauwels R; Baba M; Desmyter J; De Clercq E
J Gen Virol; 1989 Sep; 70 ( Pt 9)():2397-408. PubMed ID: 2789268
[TBL] [Abstract][Full Text] [Related]
6. Molecular cloning, expression, and biological characterization of an HTLV-II envelope glycoprotein: HIV-1 expression is permissive for HTLV-II-induced cell fusion.
Wang B; Agadjanyan MG; Srikantan V; Ugen KE; Hall W; Kaplan MH; Dang K; Williams WV; Weiner DB
AIDS Res Hum Retroviruses; 1993 Sep; 9(9):849-60. PubMed ID: 8257634
[TBL] [Abstract][Full Text] [Related]
7. Biological characterization of a simian immunodeficiency virus-like retrovirus (HTLV-IV): evidence for CD4-associated molecules required for infection.
Hoxie JA; Haggarty BS; Bonser SE; Rackowski JL; Shan H; Kanki PJ
J Virol; 1988 Aug; 62(8):2557-68. PubMed ID: 2839686
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of human immunodeficiency virus type 1 infectivity by replacing the region including Env derived from defective particles with an ability to form particle-mediated syncytia in CD4+T cells.
Kinomoto M; Mukai T; Li YG; Iwabu Y; Warachit J; Palacios JA; Ibrahim MS; Tsuji S; Goto T; Ikuta K
Microbes Infect; 2004 Aug; 6(10):911-8. PubMed ID: 15310467
[TBL] [Abstract][Full Text] [Related]
9. Selection of rabbit CD4- CD8- T cell receptor-gamma/delta cells by in vitro transformation with human T lymphotropic virus-I.
Sawasdikosol S; Hague BF; Zhao TM; Bowers FS; Simpson RM; Robinson M; Kindt TJ
J Exp Med; 1993 Oct; 178(4):1337-45. PubMed ID: 8376938
[TBL] [Abstract][Full Text] [Related]
10. Seroreactivity to human T cell leukemia/lymphoma virus type 1 and related retroviruses in multiple sclerosis patients from Denmark and the Faroes.
Rasmussen HB; Kvinesdal BB; Clausen J
Acta Neurol Scand; 1992 Jul; 86(1):91-4. PubMed ID: 1325731
[TBL] [Abstract][Full Text] [Related]
11. Increased production of human immunodeficiency virus (HIV) in HIV-induced syncytia formation: an efficient infection process.
Chowdhury MI; Koyanagi Y; Suzuki M; Kobayashi S; Yamaguchi K; Yamamoto N
Virus Genes; 1992 Jan; 6(1):63-78. PubMed ID: 1347963
[TBL] [Abstract][Full Text] [Related]
12. Inefficient transmission of HTLV-I to MOLT-4 cells by cell-free virus and cocultivation.
Kuroda MJ; Kannagi M; Masuda T; Harada S
Intervirology; 1992; 34(4):202-12. PubMed ID: 1308003
[TBL] [Abstract][Full Text] [Related]
13. Noninfectious doughnut-shaped human immunodeficiency virus type 1 can induce syncytia mediated by fusion of the particles with CD4-positive cells.
Ohki K; Kishi Y; Nishino Y; Sumiya M; Kimura T; Goto T; Nakai M; Ikuta K
J Acquir Immune Defic Syndr (1988); 1991; 4(12):1233-40. PubMed ID: 1682474
[TBL] [Abstract][Full Text] [Related]
14. Rapid syncytium formation between human T-cell leukaemia virus type-I (HTLV-I)-infected T-cells and human nervous system cells: a possible implication for tropical spastic paraparesis/HTLV-I associated myelopathy.
Mor-Vaknin N; Turgeman H; Torgeman A; Wolfson M; Huleihel M; Aboud M
Cell Biol Int; 1998; 22(2):95-103. PubMed ID: 9878096
[TBL] [Abstract][Full Text] [Related]
15. Complement-dependent cytotoxic antibodies to human T lymphotropic virus type I (HTLV-I)-infected cells in the sera of HTLV-I-infected individuals.
Plotnicky-Gilquin H; Afani A; Vernant JC; Desgranges C
Clin Exp Immunol; 1996 Jul; 105(1):39-45. PubMed ID: 8697633
[TBL] [Abstract][Full Text] [Related]
16. Induction of antibody responses that neutralize human T-cell leukemia virus type I infection in vitro and in vivo by peptide immunization.
Tanaka Y; Tanaka R; Terada E; Koyanagi Y; Miyano-Kurosaki N; Yamamoto N; Baba E; Nakamura M; Shida H
J Virol; 1994 Oct; 68(10):6323-31. PubMed ID: 8083972
[TBL] [Abstract][Full Text] [Related]
17. A new sensitive and quantitative HTLV-I-mediated cell fusion assay in T cells.
Paré ME; Gauthier S; Landry S; Sun J; Legault E; Leclerc D; Tanaka Y; Marriott SJ; Tremblay MJ; Barbeau B
Virology; 2005 Aug; 338(2):309-22. PubMed ID: 15963547
[TBL] [Abstract][Full Text] [Related]
18. Mapping of immunogenic regions of human T cell leukemia virus type I (HTLV-I) gp46 and gp21 envelope glycoproteins with env-encoded synthetic peptides and a monoclonal antibody to gp46.
Palker TJ; Tanner ME; Scearce RM; Streilein RD; Clark ME; Haynes BF
J Immunol; 1989 Feb; 142(3):971-8. PubMed ID: 2563272
[TBL] [Abstract][Full Text] [Related]
19. Transformation of CD8+ T-cells producing a strong cytopathic effect on CD4+ T-cells through syncytium formation by HTLV-II.
Miyamoto K; Kamiya T; Minowada J; Tomita N; Kitajima K
Jpn J Cancer Res; 1991 Nov; 82(11):1178-83. PubMed ID: 1752776
[TBL] [Abstract][Full Text] [Related]
20. Syncytium-inducing capacity of human immunodeficiency virus (HIV): analysis by the use of cloned viruses.
el-Farrash MA; Harada S
Microbiol Immunol; 1989; 33(7):549-59. PubMed ID: 2505024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
